Ottawa Public Health is reporting 68 more people in the city have tested positive for COVID-19. The number of COVID-19 cases in local hospitals remains steady.
Biochemist Daniela Beatriz Ori manipulates swab samples to make a real time polymerase chain reaction (RT-PCR) analysis for COVID-19 testing at the biochemistry lab of Central Navy Hospital Dr. Pedro Malloon April 28, 2020 in Buenos Aires, Argentina. (Photo by Amilcar Orfali/Getty Images)
Heavy snow falls as people wearing face masks to curb the spread of COVID-19 cross a road in Burnaby, B.C., on Monday, December 21, 2020. THE CANADIAN PRESS/Darryl Dyck
People walk past a "we're open, heated terrace dining" sign at Eli's Essentials on the Upper East Side on February 02, 2021 in New York City. (Photo by Alexi Rosenfeld/Getty Images)
Researchers at McMaster University in Ontario have been approved to begin human trials on two Canadian-made COVID-19 vaccines that are delivered by inhaled aerosol to target the lungs and upper airways.
While questions remain about the effectiveness of current vaccines in protecting against the new Omicron COVID-19 variant, experts insist that anyone who is eligible should still get their booster shot.
Just in time for the holidays, Quebec announced Tuesday it will allow private gatherings of up to 20 vaccinated people in homes starting Dec. 23 in another loosening of public health restrictions.
COVID-19 cases and hospitalizations in Ontario will continue to rise substantially, even without the Omicron variant, if vaccinations do not increase and further public health measures are not implemented, new modelling data released by the province's science table suggests.
Quebec-based biopharmaceutical company Medicago and drug maker GlaxoSmithKline says they have achieved positive efficacy and safety results from their Phase 3 trial of their plant-based COVID-19 vaccine.
Canada's tight labour market is forcing many companies to offer regular COVID-19 testing over vaccine mandates, while others are reversing previously announced inoculation requirements even as Omicron variant cases rise.
Extending both the sickness and caregiving benefits into next spring – as proposed in Bill C-2 – will cost the government approximately $873 million, the Parliamentary Budget Officer (PBO) estimates.
CTV's chief financial commentator Pattie Lovett-Reid discusses the global market sell-off over fears of a new COVID-19 variant. Read her analysis on CTVNews.ca.
The Liberal government introduced a new pandemic aid bill Wednesday afternoon that would maintain some financial supports for businesses and workers until at least the spring of 2022.
Ottawa Public Health is reporting 68 more people in the city have tested positive for COVID-19. The number of COVID-19 cases in local hospitals remains steady.
COVID-19 cases and hospitalizations in Ontario will continue to rise substantially, even without the Omicron variant, if vaccinations do not increase and further public health measures are not implemented, new modelling data released by the province's science table suggests.
Amazon.com Inc's services including Amazon Web Services (AWS), Prime Video and its namesake e-commerce website were down for thousands of users on Tuesday, according to outage tracking website Downdetector.com.
Assembly of First Nations National Chief RoseAnne Archibald says an upcoming Indigenous delegation to the Vatican has been postponed, but others involved in the trip say a final decision has not yet been made.
As Canada's two most populous provinces grapple with a surge in COVID-19 cases, concerns are swirling over whether new restrictions could be imposed before the holidays.
Quebec-based biopharmaceutical company Medicago and drug maker GlaxoSmithKline says they have achieved positive efficacy and safety results from their Phase 3 trial of their plant-based COVID-19 vaccine.
Just in time for the holidays, Quebec announced Tuesday it will allow private gatherings of up to 20 vaccinated people in homes starting Dec. 23 in another loosening of public health restrictions.
